Life Scientist > Biotechnology

Electrically activated glue used to seal broken blood vessels

07 May, 2021

A new device offers a way to seal tears and holes in blood vessels, using an electrically activated glue patch applied via a minimally invasive balloon catheter.

Lab-created heart valves grow with the recipient

03 May, 2021

If confirmed in humans, the new heart valves could prevent the need for repeated valve replacement surgeries in thousands of children each year.

Vic announces $50m for domestic mRNA vaccine manufacturing

22 April, 2021

The Victorian Government will provide $50m to establish mRNA vaccine and therapeutic manufacturing in Melbourne — the first such capability in the Southern Hemisphere.

Statins could help save Tasmanian devils

21 April, 2021

Cholesterol-lowering drugs could help delay the spread of the deadly Tasmanian devil facial tumour disease and may help protect the endangered Australian marsupials from extinction.

Why do breast cancer drugs stop working?

15 April, 2021

Although breast cancer can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse. Researchers have now found out why this happens.

Hydrogel turns cancer cells back to cancer stem cells

07 April, 2021

An innovative hydrogel — called a double network (DN) gel — can rapidly reprogram differentiated cancer cells into cancer stem cells.

Creating a genetic medicine manufacturing ecosystem

06 April, 2021 by Peter Davis

Australia has amazing scientists, respected worldwide, but do we have an ecosystem?

New nasal spray protects against COVID-19, common cold

29 March, 2021

A new drug, designed to prime the immune system in the respiratory tract and currently in development for COVID-19, is also effective against rhinovirus.

Anti-inflammatory may help reduce chemo side effects

16 March, 2021

Researchers have found that the anti-inflammatory drug anakinra substantially reduces the nerve symptoms for which vincristine chemotherapy is known.

Novavax vaccine efficacious against multiple COVID-19 strains

15 March, 2021

Novavax has announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain.

CSIRO secures a licence to develop medicinal cannabis

08 March, 2021

The licence places CSIRO at the forefront of research into the development of new cannabis medicines, which should help people with a variety of conditions.

Dual-targeting drug developed for EBV-related cancers

05 March, 2021

Hong Kong researchers have developed a novel drug for cancers associated with Epstein–Barr virus (EBV).

AstraZeneca vaccine arrives in Aus, Pfizer prevents infection

01 March, 2021

The first doses of AstraZeneca's COVID-19 vaccine have arrived in Sydney, and new data suggests that Pfizer's vaccine can reduce asymptomatic infections.

Second-gen lung-on-chip developed

26 February, 2021

Scientists have created a second-generation lung-on-chip model with life-size dimension alveoli in a stretchable membrane, made of purely biological material.

Nanoparticles boost the immune system to fight cancer

23 February, 2021

A new nanoparticle-based drug can boost the body's innate immune system and make it more effective at fighting off tumours, according to researchers.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd